Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis
Pi-Ling Chou, 1, 2,* Ya-Ping Huang, 3, 4,* Meng-Hsuan Cheng, 5–7 Kun-Ming Rau, 8, 9 Yi-Ping Fang 2, 3, 10 1School of Nursing, College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan; 2Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, T...
Guardado en:
Autores principales: | Chou PL, Huang YP, Cheng MH, Rau KM, Fang YP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e34d51c08122484ba1d5dcd8f7d8a5d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer
por: Zhao MD, et al.
Publicado: (2019) -
Noncovalent interaction-assisted drug delivery system with highly efficient uptake and release of paclitaxel for anticancer therapy
por: Wei YP, et al.
Publicado: (2017) -
Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice
por: Jin M, et al.
Publicado: (2021) -
A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance
por: Li J, et al.
Publicado: (2017) -
Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery
por: Liu K, et al.
Publicado: (2017)